Interventional MRI technology developer Imricor Medical Systems has completed patient enrollment for a clinical study to evaluate its Vision-MR ablation catheter for treating atrial flutter under real-time MRI guidance.
A total of 35 patients have enrolled for the single-center study, which is taking place at the University of Leipzig Heart Center in Germany.
Imricor's Vision-MR catheter, when used with the Advantage-MR EP recorder/stimulator system, allows physicians to perform cardiac ablations under MRI guidance, and they can individualize the ablation for each patient's unique cardiac structure and substrate and assess lesion quality, according to the vendor.
